Hjem › Syndrom med oblitererende bronkiolitt › Washington › Seattle
Kliniske studier for Syndrom med oblitererende bronkiolitt i Seattle, WA
11 studier for Syndrom med oblitererende bronkiolitt søker deltakere på steder i og rundt Seattle (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Axatilimab for Sclerotic Chronic Graft-versus-Host Disease
RekruttererFase 2
- Fred Hutch/University of Washington Cancer Consortium, Seattle
A Study of Belumosudil in Children With Chronic Graft Versus Host Disease (schoolROCK)
RekruttererFase 2
- Fred Hutchinson Cancer Research Center- Site Number : 8400002, Seattle
Belumosudil for the Pre-emptive Treatment of Patients With Chronic Graft Versus Host Disease
RekruttererFase 2
- Fred Hutch/University of Washington Cancer Consortium, Seattle
A Study to Evaluate Axatilimab Versus Best Available Therapy in Pediatric Participants With Chronic Graft-Versus-Host Disease After at Least 2 Prior Lines of Systemic Therapy (AGAVE-256)
RekruttererFase 2
- Fred Hutchinson Cancer Research Center, Seattle
Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP
RekruttererFase 2
- Seattle Childrens Hospital, Seattle
Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease
RekruttererObservasjonsstudie
- Fred Hutchinson Cancer Research Center, Seattle
Dental Cleaning to Prevent Chronic Graft-Versus-Host Disease
Rekrutterer
- Fred Hutch/University of Washington Cancer Consortium, Seattle
A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)
RekruttererFase 2
- Fred Hutchinson Cancer Research Center, Seattle
BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)
RekruttererFase 2
- Fred Hutchinson Cancer Center, Seattle
A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
RekruttererFase 3
- Fred Hutchinson Cancer Research Center, Seattle
Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)
RekruttererFase 1
- Fred Hutchinson Cancer Center, Seattle
Syndrom med oblitererende bronkiolitt-studier i andre byer
- Boston, MA13 studier
- Atlanta, GA10 studier
- New York City, NY9 studier
- Houston, TX8 studier
- Los Angeles, CA7 studier
- Miami, FL7 studier
- Durham, NC6 studier
- Baldwin Park, CA6 studier
- Tampa, FL6 studier
- Philadelphia, PA6 studier
- Washington, DC6 studier
- San Francisco, CA5 studier
Andre studier i Seattle
- Ikke-småcellet lungekreft53 studier
- Kreft (alle typer)49 studier
- Prostatakreft42 studier
- Akut myelogen leukemi41 studier
- Brystkreft39 studier
- Metastatisk kreft39 studier
- Kolorektal kreft34 studier
- Lungekreft33 studier
- Eggstokkreft30 studier
- Multipelt myelom22 studier
- Blærekreft21 studier
- Myelodysplastiske syndromer21 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.